Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ZAI Lab
Biotech
Amgen, Zai say stomach cancer candidate hits phase 3 mark
Based on the interim results, Zai Lab—a biotech that holds certain rights to bemarituzumab—will prepare a regulatory submission in China.
Gabrielle Masson
Jun 30, 2025 10:36am
Seagen finally finds new CEO—Chutes & Ladders
Nov 11, 2022 9:30am
Zai Lab to shop around CD47 after deprioritizing internal work
Aug 10, 2022 10:40am
Alchemab CEO resigns citing 'personal reasons'—Chutes & Ladders
May 27, 2022 9:30am
Camp4 taps former Translate CMO for same role—Chutes & Ladders
Mar 18, 2022 9:30am
Zai hires ex-Lilly CFO who left after 'inappropriate' behavior
Mar 15, 2022 12:30pm
